First, treatment
In general, Mallory-Weiss syndrome is first treated with medical treatment, actively correcting the deficiency or coagulation disorders of coagulation factors.
1. Non-surgical treatment:The main medical treatment methods for Mallory-Weiss syndrome include lavage of the stomach with ice saline solution containing norepinephrine, blood transfusion, intravenous infusion of hemostatics and histamine H2-receptor blockers (such as cimetidine or ranitidine), intravenous fluid administration, and gastrointestinal decompression, among other measures.
(1) Lavage of the stomach with ice saline solution of norepinephrine: Norepinephrine has a strong contractile effect on smooth muscle, especially on vascular smooth muscle. It is usually administered by adding 8mg of norepinephrine to 250ml of ice saline solution and injecting it into the stomach through a gastric tube. The solution is retained in the stomach for 20 to 30 minutes before being aspirated, and the lavage is repeated, which has a good hemostatic effect.
Individual cases are effective with the treatment of antidiuretic hormone (vasopressin), and the bleeding in the upper gastrointestinal tract can be controlled.
(2) Blood transfusion: Blood volume supplementation is an important measure for the treatment of Mallory-Weiss syndrome, which can prevent hemorrhagic shock. According to the experience of Freeark et al., the amount of blood transfusion ranges from 2000ml to 9500ml, with an average of 5770ml. Preoperative preparation for massive blood transfusion is required for cases requiring surgical treatment.
(3) Mesenteric artery embolization: Some authors have reported the use of selective mesenteric artery embolization (embolizing the left gastric artery and its branches) to treat Mallory-Weiss syndrome, considering the hemostatic effect satisfactory, but the laceration of the esophageal and cardia mucosa is severe, and the lesions are multiple, making this therapy difficult to be effective.
(4) Endoscopic hemostasis: Some authors have reported that the local area of Mallory-Weiss lesions can be treated by applying a cotton swab soaked in norepinephrine solution, or by electrocoagulation hemostasis of the active bleeding points at the tear site through the endoscope, which can achieve the purpose of cure in some cases.
(5) Compression hemostasis with a three-way tube: In recent years, most authors do not advocate the use of a three-way tube for compression hemostasis in Mallory-Weiss syndrome patients because the pressure inside the three-way tube is not sufficient to compress and stop the upper gastrointestinal artery bleeding. Exploratory surgery or post-mortem examination has confirmed that the cuff inside the three-way tube not only failed to achieve the purpose of compression hemostasis but also aggravated the laceration of the esophageal and cardia mucosa, resulting in increased bleeding.
2. Surgical treatment
(1) Indications for surgery:
① Upper gastrointestinal bleeding that cannot be stopped after regular medical treatment or has transformed into massive bleeding;
② Large amounts of upper gastrointestinal bleeding stop after conservative medical treatment but recur, and the amount of bleeding is large, and it is estimated that it is difficult to control with further medical treatment;
③ Patients with massive hematemesis and critical condition.
Mallory-Weiss syndrome is often diagnosed clinically as 'unexplained massive upper gastrointestinal bleeding' and undergoes exploratory surgery. In fact, Mallory-Weiss syndrome is just one of the causes of upper gastrointestinal bleeding.
(2) Preoperative preparation: Evaluate the amount of bleeding; perform gastroscopy to determine the specific bleeding site; exclude bleeding caused by esophageal varices rupture, and perform surgical exploration under general anesthesia.
(3) Surgical procedure:
The patient is placed in a supine position and a median or para-medial incision is made in the upper abdomen. The abdomen is opened layer by layer. After the abdomen is opened, the stomach and duodenum are palpated first to exclude upper gastrointestinal bleeding caused by other reasons. The majority of Mallory-Weiss syndrome patients are normal during endoscopy and palpation, and it is difficult to find the bleeding site and lesion.
After the endoscopy and palpation, the stomach and lower esophagus should not be freed immediately. A diagonal incision is made in the middle 1/3 of the anterior wall between the greater curvature and lesser curvature of the stomach, exposing the stomach cavity. The blood and blood clots in the stomach are aspirated with a suction device, and a small gauze is temporarily used to block the pylorus of the stomach to carefully observe the source of bleeding in the upper gastrointestinal tract.
③If bleeding is seen above the pylorus but no hemorrhagic lesions are visible, extend the incision at both ends of the anterior gastric wall by 4 cm, so that the upper and lower ends of the incision are each about 4 cm away from the pylorus and the esophagus-gastric junction. Flip the gastric wall incision to the left and right sides and outward, which can clearly display the entire gastric cavity mucosa for examination. However, the mucosa at the esophagus-gastric junction is still not visible. In this situation, the surgeon can use a curved hemostat to clamp the front end of the gastric tube inside the gastric cavity and ask the anesthesiologist to fix the gastric tube at the patient's external nostril. The surgeon can then pull downwards and forwards with appropriate force on the front end of the gastric tube clamped by the hemostat, which can bring the mucosa of the cardia along with the grayish mucosa of the lower esophagus into the surgical field, thus exposing the mucosal folds or concave areas of the esophagus-gastric junction. This can further help to discover the mucosal tears and bleeding at the esophagus-cardiac orifice. If a Deaver retractor or S-shaped retractor is inserted into the gastric cavity and slightly pulled, it is more helpful to expose the surgical field.
④Tie off (suture) each visible mucosal tear at the esophageal-cardiac orifice and submucosal active arteriovenous hemorrhage points one by one to stop bleeding or coagulate with electricity. After that, suture each mucosal tear along with the submucosa and muscular layer continuously inside the gastric cavity. The best suture thread to use is 5-0 absorbable suture. First, suture from the lower end of the mucosal tear upwards, tie the knot after reaching the upper end of the mucosal tear; then, you can reverse the needle from the upper end of the mucosal tear and suture downwards in the same manner, making the two suture lines cross each other. Tie the knot after reaching the lower end of the tear. This double-cross continuous suture technique for repairing esophageal-cardiac orifice mucosal tears has a more reliable hemostatic effect, but it is important to include more of the deep muscular layer tissue during suture to prevent the formation of hematoma or continued bleeding at the muscular layer tear site beneath the mucosa. After suture, check the suture site repeatedly and carefully for bleeding, and stop any bleeding points.
⑤When encountering cases of esophageal-cardiac orifice full-thickness penetrating tears, first close the tear from inside the gastric cavity with absorbable suture in a continuous full-thickness inversion suture technique. Then, use a small round needle and fine silk thread to suture the serosal or muscular layer (outer layer) of the tear in an interrupted manner. Subsequently, use a pedicled diaphragmatic flap or pericardial patch to suture and cover the tear, making the repair of the tear more safe and reliable and preventing postoperative tear fistula.
⑥Suture the incision of the anterior gastric wall with interrupted or continuous inversion suture technique. For patients with esophageal hiatus hernia or gastroesophageal reflux symptoms before surgery, concurrent anti-reflux surgery should be performed, such as fundoplication. Some authors advocate installing a gastric gastrostomy tube by making an additional incision on the anterior gastric wall after closing the incision of the anterior gastric wall for postoperative gastrointestinal decompression. The advantage is that the nasogastric tube can be removed after the operation, avoiding the continued compression of the mucosal tear at the esophageal cardiac orifice, which may cause secondary hemorrhage. Some authors, however, advocate the continued use of a nasogastric tube for gastrointestinal decompression after surgery. Both opinions have their merits. Currently, in clinical practice, after surgical treatment for Mallory-Weiss syndrome, nasal gastric tubes are generally used for gastrointestinal decompression.
⑦ Suture the abdominal incision in layers and close the abdomen.
3. Postoperative management:The postoperative management of Mallory-Weiss syndrome patients includes:
(1) Fast for the first week after surgery, continue gastrointestinal decompression, closely observe the nature and quantity of gastrointestinal drainage fluid, and be vigilant about the recurrence of upper gastrointestinal bleeding postoperatively.
(2) Use parenteral hyperalimentation to maintain the patient's nutrition, pay attention to correct water and electrolyte imbalances and acid-base disturbances; use highly effective broad-spectrum antibiotics to prevent abdominal and incisional infections.
(3) Remove the gastric tube (gastric fistula tube should be removed on the 10th day after surgery) on the 5th or 7th day after the operation, depending on the condition.
(4) Stop gastrointestinal decompression and gradually resume oral intake.
(5) Timely management of postoperative complications.
4. Surgical effects:In 1964, Freeark et al. reported that 12 cases of Mallory-Weiss syndrome were cured in 7 cases after surgical suture and hemostasis, 3 died of postoperative pneumonia complicated with acute liver dysfunction or myocardial infarction, and 2 died of postoperative gastric wall fistula.
Some authors have reported that in 13 cases of upper gastrointestinal bleeding of unknown etiology, no bleeding cause was found during laparotomy, but bleeding stopped and the patient recovered after undergoing a 'blind' subtotal gastrectomy. Other authors have reported that patients with unexplained upper gastrointestinal bleeding who underwent a 'blind' subtotal gastrectomy died, and it was later found that the cause of bleeding was Mallory-Weiss syndrome. Clinical experience has repeatedly shown that if Mallory-Weiss lesions are missed during surgical exploration, patients often die of upper gastrointestinal bleeding postoperatively.
According to recent large case reports, the surgical efficacy of Mallory-Weiss syndrome is satisfactory, with rare cases of postoperative bleeding recurrence and a mortality rate of less than 5%.
The choice of treatment method is mainly based on the severity of bleeding, the patient's overall condition, and whether there are other concurrent diseases. In the past, the surgical rate for this syndrome was as high as 46%, but recent reported data show that the surgical rate has明显下降明显下降, and in the absence of severe massive bleeding, non-surgical treatment can usually be adopted, but it is necessary to promptly replenish blood volume, prevent aspiration of respiratory tract, fasting, and the use of drugs to inhibit gastric acid secretion (such as H2 receptor antagonists), closely monitor hemodynamic changes, and try to correct coagulation dysfunction. Other non-surgical treatment measures are the same as those for ulcer bleeding, and can include lavage of the stomach with ice water, oral administration of cimetidine, intravenous infusion of pituitary posterior lobe extract and vitamin K, and also balloon compression for hemostasis. Recently, a transparent esophageal balloon made of polyurethane film has been used, which is inserted into the stomach through an endoscope and observed under direct vision for hemostasis. This method has the following advantages over the previous Sengstaken-Blakemore balloon compression hemostasis method:
(1) The success rate of hemostasis is high, almost reaching 100%.
(2) This method can observe whether bleeding has stopped under direct vision.
(3) It can be used for a relatively long time, and hemostasis may also be achieved in patients with coagulation dysfunction.
(4) This balloon has good quality and exerts uniform pressure on the surrounding area.
(5) Select a lower effective hemostatic pressure, maintain it for 12 to 24 hours, which can usually achieve hemostasis and is not easy to cause esophageal injury even if it is left in place for a long time.
Nusbaum introduced selective infusion of vasopressin through the left gastric artery to control bleeding, which achieved good hemostatic effects and could be performed immediately after angiography to identify the bleeding site. Endoscopic treatment also has many successful experiences, including electrocoagulation hemostasis, ND:YAG laser treatment, and local sclerosing agent injection, etc. Bataller et al. reported 50 cases of Mallory-Wiess syndrome, 13 of which had active bleeding, all of which were treated successfully with sclerosing agent injection (1/10000 adrenaline 1% polidocanol) under endoscopy.
5. Most cases of esophageal mucosal tear syndrome can be cured by non-surgical therapy, but surgery is still required in the following situations:
(1) Life-threatening massive hemorrhage, Hlastings (1981) reported that less than 500ml of blood transfusion does not require surgical treatment, and more than 1500ml of blood transfusion requires consideration of surgery; 77.8% of those with more than 2000ml of blood transfusion require surgery.
(2) Recurrent bleeding despite active treatment.
(3) Suspected esophageal rupture.
Surgery is generally easy. After high gastric incision, carefully examine the esophagus, gastric fundus, and esophagus-gastric junction. If esophageal mucosal tears are found, continuous suture can achieve hemostasis. However, it should be noted that small and unobvious tears may be missed, and there have been reports of postoperative death due to this. Some authors perform vagotomy and pyloroplasty at the same time to try to control possible pathogenic factors, but it is generally not necessary, and a few cases may require subtotal gastrectomy.
II. Prognosis
Recently reported that 8.5% to 30% of patients with esophageal mucosal tear syndrome require surgical treatment, with a mortality rate of 0 to 10%. The mortality rate of non-surgical treatment is 0 to 14%. Recurrent bleeding is rare, and the prognosis is generally good, especially for non-drinkers. The high-risk factor for recurrent bleeding is the presence of portal hypertension.